These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 11503843)

  • 1. Serotonin reuptake inhibitor antidepressants and pregnancy: many unanswered questions.
    Prescrire Int; 1999 Oct; 8(43):157-9. PubMed ID: 11503843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal complications after intrauterine exposure to SSRI antidepressants.
    Prescrire Int; 2004 Jun; 13(71):103-4. PubMed ID: 15233148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].
    Bailly D
    Presse Med; 2006 Oct; 35(10 Pt 2):1507-15. PubMed ID: 17028514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.
    Diav-Citrin O; Shechtman S; Weinbaum D; Wajnberg R; Avgil M; Di Gianantonio E; Clementi M; Weber-Schoendorfer C; Schaefer C; Ornoy A
    Br J Clin Pharmacol; 2008 Nov; 66(5):695-705. PubMed ID: 18754846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitor usage patterns as risk factors for hospitalization.
    Sheffield RE; Lo Sasso AT; Young CH; Way K
    Adm Policy Ment Health; 2002 Nov; 30(2):121-39. PubMed ID: 12680617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.
    Gentile S; Bellantuono C
    J Clin Psychiatry; 2009 Mar; 70(3):414-22. PubMed ID: 19254517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions.
    Mandrioli R; Mercolini L; Saracino MA; Raggi MA
    Curr Med Chem; 2012; 19(12):1846-63. PubMed ID: 22414078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An imperfect literature and evidence-based medicine.
    Freeman MP
    J Clin Psychiatry; 2009 Mar; 70(3):412-3. PubMed ID: 19317958
    [No Abstract]   [Full Text] [Related]  

  • 10. SSRI antidepressants and birth defects.
    Prescrire Int; 2006 Dec; 15(86):222-3. PubMed ID: 17167929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating functional impairment of autism with selective serotonin-reuptake inhibitors.
    Moore ML; Eichner SF; Jones JR
    Ann Pharmacother; 2004 Sep; 38(9):1515-9. PubMed ID: 15292500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts.
    Schneeweiss S; Patrick AR; Solomon DH; Dormuth CR; Miller M; Mehta J; Lee JC; Wang PS
    Pediatrics; 2010 May; 125(5):876-88. PubMed ID: 20385637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment.
    Fava M; Judge R; Hoog SL; Nilsson ME; Koke SC
    J Clin Psychiatry; 2000 Nov; 61(11):863-7. PubMed ID: 11105740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment.
    Judge R; Parry MG; Quail D; Jacobson JG
    Int Clin Psychopharmacol; 2002 Sep; 17(5):217-25. PubMed ID: 12177584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remission of SSRI-induced akathisia after switch to nefazodone.
    Chelben J; Strous RD; Lustig M; Baruch Y
    J Clin Psychiatry; 2001 Jul; 62(7):570-1. PubMed ID: 11488371
    [No Abstract]   [Full Text] [Related]  

  • 16. Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
    Maina G; Albert U; Salvi V; Bogetto F
    J Clin Psychiatry; 2004 Oct; 65(10):1365-71. PubMed ID: 15491240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. If everyone were on Prozac...
    Gupta S
    Time; 2003 Jan; 161(3):81. PubMed ID: 12545568
    [No Abstract]   [Full Text] [Related]  

  • 18. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial.
    Kroenke K; West SL; Swindle R; Gilsenan A; Eckert GJ; Dolor R; Stang P; Zhou XH; Hays R; Weinberger M
    JAMA; 2001 Dec; 286(23):2947-55. PubMed ID: 11743835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withdrawal syndromes after paroxetine and sertraline discontinuation.
    Fava GA; Grandi S
    J Clin Psychopharmacol; 1995 Oct; 15(5):374-5. PubMed ID: 8830071
    [No Abstract]   [Full Text] [Related]  

  • 20. Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.
    Gunasekara NS; Noble S; Benfield P
    Drugs; 1998 Jan; 55(1):85-120. PubMed ID: 9463792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.